This systematic, retrospective chart review examined real-life outcomes in Spanish and Portuguese patients with R/R FLT3-ITD-mutated AML from the Programa Español de Tratamientos en Hematología (PETHEMA) epidemiologic registry. This evidence concerns the gene FLT3 and acute myeloid leukemia.